Ashland Speciality Ingredients receives EXCiPACT GMP certification

Published: 30-May-2017
Ingredients Regulatory

Certification as pharmaceutical excipient suppliers for Belgium site

Ashland Speciality Ingredients site in Doel, Belgium has recently been awarded an EXCiPACT GMP Certificate from SGS, one of EXCIPACT’s internationally-recognised Certification Bodies.

The Certificate demonstrates that the Ashland Speciality Ingredients (ASI) site in Doel, Belgium, manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard.

Its scope covers the production of methylcellulose (MC), hydroxypropylmethylcellulose (HPMC) and methylhydroxyethylcellulose (MHEC) as pharmaceutical excipients.

  • Companies:
  • Ashland
  • EXCiPACT
See more

You may also like

Regulatory

Illinois Corn Processing site receives EXCiPACT certification

Read more
The certificate demonstrates the site manufactures ethyl alcohol intended for use as a pharmaceutical excipient according to the 2017 EXCiPACT GMP certification standard

Trending Articles

  1. Accelerating and enhancing toxicology assessments Infographic guides users through ToxHQ’s speedy assessment features
  2. Get ahead in the pharmaceutical industry with a Manufacturing Chemist subscription With a Manufacturing Chemist subscription you receive exclusive access to the latest news, technical insights, regulatory updates, and market intelligence
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Merck jumps on the GLP-1 therapeutic bandwagon by licensing Hansoh Pharma's HS-10535 Merck will be responsible for the development, manufacture and commercialisation of the investigational preclinical oral GLP-1 receptor agonist
  4. Bayer's acoramidis recommended for approval by the EMA's CHMP for cardiomyopathy The orally administered transthyretin (TTR) stabiliser is suitable for patients with transthyretin amyloid cardiomyopathy, demonstrating at least a 90% TTR stabilisation capacity and a reduction in cardiovascular-related hospitalisations
  5. Rousselot Biomedical launches EU MDR compliant gelatin range From May 2024, all devices placed on the European market must conform with the EU Medical Device Regulation (MDR)

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Regulatory

Illinois Corn Processing site receives EXCiPACT certification

The certificate demonstrates the site manufactures ethyl alcohol intended for use as a pharmaceutical excipient according to the 2017 EXCiPACT GMP certification standard
Regulatory

JRS Pharma and Gujurat Microwax achieve EXCiPACT certification

EXCiPACT has certified sites in 21 countries to date including the UK, US, Japan and China
Ingredients

Colorcon Westpoint site gains EXCiPACT GMP and GDP Certificate from SGS

Site in Pennsylvania manufactures and distributes lake pigments for use as pharmaceutical excipients
Ingredients

Ashland launches new excipient solutions for improved drug delivery

Ashland will premieres the new products at upcoming pharma shows at CPhI in Frankfurt, Germany, and AAPS PharmSci360, San Antonio, Texas
Regulatory

SGS certifies Valtris Speciality Chemical site as GMP

Certification body of EXCiPACT, SGS, has certified that the Cleveland site manufactures metal stearate to GMP standard
Manufacturing

Qualicaps Romania gains EXCiPACT GMP certification

The certification scope covers the manufacture of gelatin capsule shells for the pharmaceutical and consumer health industries
Regulatory

SGS certifies Dow's Stade site with EXCiPACT GMP standard

The certificate demonstrates that this site manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard
Subscribe now